Greetings from San Diego. I’m Jonathan Worthen, West Coast Biotechnology and Life Sciences reporter. Today, we explore the complex decisions federal officials must navigate regarding vaccine policies, the ongoing search for a permanent director at the Centers for Disease Control and Prevention (CDC), and the challenges regulations pose for patients seeking innovative treatments for serious intestinal infections.
As a personal note, I am beginning my maternity leave today, which means it will be some time before my byline reappears. In the interim, I encourage you to read the excellent work of my talented colleagues. I look forward to following their progress from home while caring for my children.
Federal Response to Delayed Vaccine Review By RFK Jr.
In a recent development, Donald Trump has fulfilled his campaign promise by appointing Robert F. Kennedy Jr., a vocal critic of vaccines, to lead the federal Department of Health. His administration has since reorganized a crucial vaccine advisory committee. However, a federal judge has ruled that the reorganization of the Advisory Committee on Immunization Practices (ACIP) and subsequent changes to the childhood vaccination schedule are likely illegal. This places federal authorities in a position where they must now decide on an appropriate response to the court’s orders.
The decision is complicated, as the White House has been a staunch supporter of Kennedy’s health policies, even as public polls indicate that changes in vaccine policy are largely unpopular, especially in an election year. A source familiar with the situation informed our team that the administration has yet to decide whether to appeal the ruling; alternatively, it could consider reconfiguring the ACIP once more.
At present, the committee’s preliminary recommendations have been overridden by judicial mandates, including the postponement of administering the hepatitis B vaccine at birth for mothers who test negative for the virus and the fragmentation of the combined measles, mumps, rubella, and varicella vaccinations. Consequently, ACIP finds itself in a state of uncertainty, although Kennedy or the CDC director, whose position remains vacant, could still issue new vaccine recommendations.
High-Stakes Search for New CDC Director
In light of the vacancy at the CDC, Chris Klomp, Secretary of Medicare and a rising figure at the federal Department of Health, is playing a pivotal role in the search for a successor to fill this critical post, which has been marked by controversy during the Trump administration. At the recent STAT Breakthrough Summit East in New York, Klomp shared insights on how he is approaching this high-stakes challenge.
He emphasized the need for a candidate with extensive experience, deep expertise, and unwavering moral integrity to lead such a complex and essential government agency. Klomp expressed concern over the diminishing trust in the CDC, noting that this issue predates the current administration. Klomp is vetting candidates both through virtual interviews and in-person meetings, and he confirmed that Kennedy is actively involved in the selection process.
According to Klomp, about six candidates have advanced to later interview stages. If the White House does not appoint a new director by Wednesday, it will lose the opportunity to retain Jay Bhattacharyya as acting director, underscoring the urgency of the situation.
Trust Issues in Medicine Exacerbated by AI Adoption
Companies like OpenAI and Anthropic are making significant headway in the medical sector, asserting that their AI-driven tools can benefit both patients and healthcare providers. However, the introduction of these technologies has revealed errors, which could further erode public trust in the healthcare system, as highlighted by physician-researcher Oni Blackstock in a recent STAT opinion piece.
Blackstock points out that the medical field is an attractive target for AI companies because it possesses vast amounts of data, crucial for algorithm training. Nevertheless, a 2025 public opinion poll indicated that a considerable 58% of respondents lack confidence in the healthcare system’s ability to use AI responsibly.
To transform this landscape, Blackstock argues for a more inclusive decision-making process regarding the purchase, management, and application of AI tools. Emphasizing the importance of patient representation, he notes that those who have faced discrimination within the healthcare system are the least likely to trust its intentions regarding AI.
Impact of Stricter FDA Regulations on Fecal Transplants
For patients battling severe Clostridioides difficile infections, fecal transplants can be life-saving, as they reset the gut microbiome. However, stringent regulations imposed by the Food and Drug Administration (FDA) on stool banks have made these essential treatments increasingly inaccessible, as reported by STAT’s Eric Budman.
In both 2022 and 2023, the FDA approved two human waste-derived drugs aimed at preventing C. diff recurrence. Shortly thereafter, the agency intensified its scrutiny of OpenBiome, a nonprofit that operates as a fecal bank, leading to the suspension of its long-standing practice of relaxed regulatory enforcement and halting sample shipments.
Tighter regulations created significant hurdles for individuals like Blanca Morales, whose son, Mundo, was grappling with a severe C. diff infection. With approved treatments unavailable for children, Morales faced an arduous journey to secure off-label treatment for her son, who she feared might not survive without urgent intervention.
Match Day Results Reflect Immigration Policy Effects on Medical Trainees
Each year, medical students experience apprehension as they unveil envelopes revealing the locations of their future training programs. This year’s Match Day, held recently, brought an additional layer of anxiety for international students due to recent changes in federal immigration policy, such as travel bans and delays in visa processing.
The National Residency Matching Program reported that the match rate among non-U.S. students attending medical schools abroad plummeted to 56.4%, the lowest figure recorded in five years. Nearly half of these applicants were unable to secure a residency position. In contrast, the match rate for fourth-year medical students at U.S. schools stood at a robust 93.5%.
Study Links Loss of Insurance with Worsening Diabetes Outcomes
The recent One Big Beautiful Act, which included significant cuts to Medicaid, is expected to exacerbate health outcomes for millions of individuals with diabetes. A study from researchers at Oregon Health & Science University analyzed electronic medical records for over 39,000 patients, identifying more than 5,000 whose insurance coverage was unstable, defined as having no insurance for two consecutive visits to a community health center.
The findings, published in JAMA Health Forum, revealed that individuals experiencing coverage instability had higher HbA1C levels, indicating poor blood sugar control, and required more insulin compared to those with consistent insurance. While the study found no immediate evidence linking insurance loss to severe complications, such as kidney failure or amputation, researchers cautioned that such issues may take time to manifest.
Study lead author Nathalie Huguet remarked that these findings are early warning signs, highlighting the growing challenges of managing diabetes without insurance coverage.
What We Are Reading
The Trump administration navigates CDC leadership changes, Bloomberg reports. In a separate article, a woman goes into labor in a Florida hospital and appears in Zoom court after refusing a C-section (ProPublica). Elsewhere, STAT discusses how the Iran conflict is affecting pharmaceutical supply chains, emphasizing that promoting ‘gold standard science’ may face challenges. Lastly, The Conversation highlights the chaos caused by hospital cyber-attacks, endangering patient safety and disrupting care.
